CLINICAL_TRIALS
trial_result
· 2015-07-09
Clinical Trial Update: The Feasibility of Florbetapir Quantitation in Europe [Phase 4]
Summary
Phase 4 study evaluating the feasibility of quantifying florbetapir in Europe for Alzheimer's disease; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-07-09